Mindset Health’s Nerva gut-brain therapy is now available to eligible US Original Medicare patients at $0 out-of-pocket through the CMS ACCESS Model. The update expands reimbursement/access for Nerva in IBS and other gut-brain disorders, which is supportive for adoption prospects, though it is unlikely to drive immediate broad market repricing.
Mindset Health’s Nerva gut-brain therapy is now available to eligible US Original Medicare patients at $0 out-of-pocket through the CMS ACCESS Model. The update expands reimbursement/access for Nerva in IBS and other gut-brain disorders, which is supportive for adoption prospects, though it is unlikely to drive immediate broad market repricing.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.20